Wu Jiong, Fan Daiming, Shao Zhimin, Xu Binghe, Ren Guosheng, Jiang Zefei, Wang Yongsheng, Jin Feng, Zhang Jin, Zhang Qingyuan, Ma Fei, Ma Jinli, Wang Zhonghua, Wang Shusen, Wang Xiaojia, Wang Shu, Wang Haibo, Wang Tao, Wang Xiang, Wang Jing, Wang Jia, Wang Biyun, Fu Li, Li Hongyuan, Shi Yehui, Gan Lu, Liu Yunjiang, Liu Jian, Liu Zhenzhen, Liu Qiang, Sun Qiang, Cheng Wenwu, Yu Keda, Tong Zhongsheng, Wu Xinhong, Song Chuangui, Zhang Jianguo, Zhang Jian, Li Junjie, Li Bin, Li Man, Li Huiping, Yang Wentao, Yang Hongjian, Yang Benlong, Bu Hong, Shen Juping, Shen Zhenzhou, Chen Yiding, Chen Ceshi, Pang Da, Fan Zhimin, Zheng Ying, Yu Xiaoli, Liu Guangyu, Hu Xichun, Ling Yiqun, Tang Jinhai, Yin Yongmei, Geng Cuizhi, Yuan Peng, Gu Yajia, Chang Cai, Cao Xuchen, Sheng Yuan, Huang Yuanxi, Huang Jian, Peng Weijun, Zeng Xiaohua, Xie Yuntao, Liao Ning
Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
Holist Integr Oncol. 2022;1(1):7. doi: 10.1007/s44178-022-00007-8. Epub 2022 Jul 5.
Breast cancer is now the most common malignant tumor worldwide. About one-fourth of female cancer patients all over the world suffer from breast cancer. And about one in six female cancer deaths worldwide is caused by breast cancer. In terms of absolute numbers of cases and deaths, China ranks first in the world. The CACA Guidelines for Holistic Integrative Management of Breast Cancer were edited to help improve the diagnosis and comprehensive treatment in China.
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to classify evidence and consensus.
The CACA Guidelines for Holistic Integrative Management of Breast Cancer include the epidemiology of breast cancer, breast cancer screening, breast cancer diagnosis, early breast cancer treatment, advanced breast cancer treatment, follow-up, rehabilitation, and traditional Chinese medicine treatment of breast cancer patients.
We to standardize the diagnosis and treatment of breast cancer in China through the formulation of the CACA Guidelines.
乳腺癌是目前全球最常见的恶性肿瘤。全球约四分之一的女性癌症患者患有乳腺癌。全球约六分之一的女性癌症死亡由乳腺癌导致。就病例数和死亡数的绝对数量而言,中国位居世界第一。编辑《中国抗癌协会乳腺癌整合诊疗指南》以帮助改善中国的乳腺癌诊断和综合治疗。
采用推荐分级的评估、制定与评价(GRADE)方法对证据和共识进行分级。
《中国抗癌协会乳腺癌整合诊疗指南》涵盖乳腺癌的流行病学、乳腺癌筛查、乳腺癌诊断、早期乳腺癌治疗、晚期乳腺癌治疗、随访、康复以及乳腺癌患者的中医治疗。
我们通过制定《中国抗癌协会乳腺癌整合诊疗指南》来规范中国乳腺癌的诊断和治疗。